MedTrace Logo

Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS

NCT05746442 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2026-04-01

No results posted yet for this study

Summary

The goal of this research study is to test how well an automated text messaging smoking treatment program helps smokers with HIV quit smoking.

Conditions

  • Smoking Cessation
  • HIV

Interventions

BEHAVIORAL

Smartphone-delivered Automated Messaging

An interactive smartphone based intervention will provide weekly smoking-related assessments and personalized automated messages designed to increase motivation, self-efficacy, use of coping skills, social support and to reduce nicotine withdrawal symptoms and stress for a 26 week period.

DRUG

Nicotine patch

Participants will be provided with a 8 week supply of nicotine patches

BEHAVIORAL

Brief Advice to Quit and Smoking Cessation Self Help Materials

Participants will receive self-help materials from Khmer Quit Now, a national smoking cessation campaign in Cambodia

BEHAVIORAL

Diet Assessment

Participants will be asked to complete brief weekly smartphone assessments about their diet for a 26-week period

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Oklahoma

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Damon Vidrine, Dr.PH · Moffitt Cancer Center

  • Thanh Bui, Dr.PH · Phnom Penh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • Cambodia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05746442 on ClinicalTrials.gov